Harsen

Harsen Pharmaceutical Group is a prominent Chinese pharmaceutical company headquartered in Kunshan, Jiangsu Province. The company focuses on the research, development, production, and sale of chemical drugs, including both active pharmaceutical ingredients (APIs) and finished dosage forms. Its extensive product line covers several therapeutic areas such as anti-infectives, cardiovascular health, and digestive system disorders. Harsen is recognized for its large-scale manufacturing capabilities and adherence to Good Manufacturing Practice (GMP) standards, supplying essential medications to the Chinese market and abroad. Since its listing on the Shanghai Stock Exchange in 2016, the company has continued to expand its production capacity and R&D capabilities to maintain its competitive position in the generic drug industry.